Lisinopril vs Pembrolizumab
Lisinopril vs Pembrolizumab: Overview
This comparison examines the pharmacological differences between Lisinopril and Pembrolizumab.
Mechanism of Action
Lisinopril: ACE inhibitor preventing conversion of angiotensin I to angiotensin II.
Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.
Pharmacokinetics
Half-life: Lisinopril β 12 hours; Pembrolizumab β 26 days.
Chemical Properties
Molecular Formula: Lisinopril β C21H31N3O5.
Molecular Weight: Lisinopril β 405.4900 g/mol.
Type: Lisinopril β Small molecule; Pembrolizumab β Antibody.